0001593968-21-001633.txt : 20210616
0001593968-21-001633.hdr.sgml : 20210616
20210616190127
ACCESSION NUMBER: 0001593968-21-001633
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210614
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ignelzi Troy A.
CENTRAL INDEX KEY: 0001579829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 211022813
MAIL ADDRESS:
STREET 1: C/O ESPERION THERAPEUTICS, INC.
STREET 2: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-06-14
0001771917
Karuna Therapeutics, Inc.
KRTX
0001579829
Ignelzi Troy A.
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
false
true
false
false
Chief Financial Officer
Common Stock
2021-06-16
4
M
false
2248
9.2
A
15248
D
Common Stock
2021-06-16
4
S
false
2248
129.45
D
13000
D
Common Stock
2021-06-14
4
M
false
900
9.2
A
13900
D
Common Stock
2021-06-14
4
S
false
900
132.52
D
13000
D
Common Stock
2021-06-16
4
M
false
352
9.2
A
13352
D
Common Stock
2021-06-16
4
S
false
352
128.4
D
13000
D
Option (right to buy)
9.20
2021-06-16
4
M
false
2248
0
D
2029-03-28
Common Stock
2248
10031
D
Option (right to buy)
9.20
2021-06-14
4
M
false
900
0
D
2029-04-07
Common Stock
900
1605
D
Option (right to buy)
9.20
2021-06-16
4
M
false
352
0
D
2029-04-07
Common Stock
352
1253
D
This option vests and becomes exercisable in thirty-six equal monthly installments beginning on April 1, 2019.
/s/ Troy Ignelzi
2021-06-16